Cost of HIV and determinants of health care costs in HIV-positive patients in Germany: results of the DAGNÄ K3A Study-Reference-Cited by-同舟云学术

Cost of HIV and determinants of health care costs in HIV-positive patients in Germany: results of the DAGNÄ K3A Study

Published:2012-09-19 Issue:5 Volume:14 Page:799-808
ISSN:1618-7598
Container-title:The European Journal of Health Economics
language:en
Short-container-title:Eur J Health Econ

Author:

Mostardt Sarah,Hanhoff Nikola,Wasem Jürgen,Goetzenich Armin,Schewe Knud,Wolf Eva,Mayr Christoph,Jaeger Hans,Pfaff Holger,Dupke Stephan,Neumann Anja

Publisher

Springer Science and Business Media LLC

Subject

Health Policy,Economics, Econometrics and Finance (miscellaneous)

Link

http://link.springer.com/content/pdf/10.1007/s10198-012-0425-4.pdf

Reference32 articles.

1. Epidemiologisches Bulletin Nr. 43. Robert-Koch-Institut. Available at: http://edoc.rki.de/documents/rki_fv/reke9T04SXOU/PDF/24ygyz31WrwGQ.pdf (2010)

2. Epidemiologisches Bulletin Nr. 46. Robert-Koch-Institut. Available at: http://edoc.rki.de/documents/rki_fv/relMeRcwf8zQQ/PDF/24ZNf9TFple7E.pdf (2010)

3. Claes C, Mittendorf T, Stoll M: Versorgung von HIV-Patienten in Deutschland: Herausforderungen der Zukunft. Diskussionspapier Nr. 424. Available at: http://www.wiwi.uni-hannover.de/Forschung/Diskussionspapiere/dp-424.pdf (August 2009)

4. Krankheitskosten in Mio. € für Deutschland. Statistisches Bundesamt. Available at: http://www.gbe-bund.de/oowa921-install/servlet/oowa/aw92/dboowasys921.xwdevkit/xwd_init?gbe.isgbetol/xs_start_neu/&p_aid=3&p_aid=80359074&nummer=553&p_sprache=D&p_indsp=-&p_aid=46725082 (2010)

5. Sendi, P.P., Bucher, H.C., Harr, T., Craig, B.A., Schwietert, M., Pfluger, D., et al.: Cost effectiveness of highly active antiretroviral therapy in HIV-infected patients. Swiss HIV Cohort Study. AIDS. 13(9), 1115–1122 (1999)

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Determinants and economic burden of HIV/AIDS in Iran: a prospective study;BMC Health Services Research;2023-03-14

2. Cost-savings and potential cost-savings through the distribution of generic antiretroviral drugs within the statutory health insurance market of Germany between January 2017 and June 2019;BMC Health Services Research;2022-01-13

3. A 10-year economic analysis of HIV management in Greece: evidence of efficient resource allocation;Current Medical Research and Opinion;2021-12-23

4. Costs and mortality associated with HIV: a machine learning analysis of the French national health insurance database;Journal of Public Health Research;2021-11-29

5. Intersectoral costs of sexually transmitted infections (STIs) and HIV: a systematic review of cost-of-illness (COI) studies;BMC Health Services Research;2021-10-29